Dongjun Dai
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Circular RNAs in diseases
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 10
- Breast Cancer Treatment Studies 3
- Co-authors
- Xian Wang (15 shared papers)Hongchuan Jin (12 shared papers)Liyuan Zhu (6 shared papers)Hanying Wang (3 shared papers)Shiwei Duan (24 shared papers)Lifeng Feng (4 shared papers)Yiran Zhu (2 shared papers)Wenxia Xu (4 shared papers)
- Journals
- Biomedical Reports (5 papers)Oncotarget (3 papers)PeerJ (3 papers)PLoS ONE (3 papers)Cancers (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Dongjun Dai
59 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 600
- Molecular Biology 1.0k
- Oncology 208
- Otorhinolaryngology 27
- Biological Psychiatry 15
Countries citing papers authored by Dongjun Dai
This map shows the geographic impact of Dongjun Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongjun Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongjun Dai more than expected).
Fields of papers citing papers by Dongjun Dai
This network shows the impact of papers produced by Dongjun Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongjun Dai. The network helps show where Dongjun Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongjun Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 344 | |
| 2 | 2019 | 156 | |
| 3 | 2016 | 89 | |
| 4 | 2020 | 75 | |
| 5 | 2018 | 72 | |
| 6 | Epigenetic regulation of alternative splicing. | 2018 | 58 |
| 7 | 2017 | 53 | |
| 8 | 2014 | 46 | |
| 9 | 2016 | 38 | |
| 10 | 2014 | 37 | |
| 11 | 2015 | 33 | |
| 12 | 2014 | 30 | |
| 13 | Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study. | 2018 | 28 |
| 14 | 2022 | 27 | |
| 15 | 2017 | 25 | |
| 16 | 2018 | 24 | |
| 17 | 2015 | 21 | |
| 18 | 2020 | 21 | |
| 19 | 2019 | 19 | |
| 20 | 2022 | 19 |
About Dongjun Dai
Dongjun Dai is a scholar working on Cancer Research, Otorhinolaryngology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Epigenetics and DNA Methylation (11 papers), Cancer-related molecular mechanisms research (10 papers), RNA Research and Splicing (6 papers), Cancer-related gene regulation (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Ferroptosis and cancer prognosis (4 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Cancer Research (600 citations), Molecular Biology (1.0k citations), Oncology (208 citations), Otorhinolaryngology (27 citations) and Biological Psychiatry (15 citations). Dongjun Dai has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xian Wang, Hongchuan Jin, Liyuan Zhu, Hanying Wang, Shiwei Duan, Lifeng Feng, Yiran Zhu, Wenxia Xu, Danjie Jiang and Vivian Y. Shin. Their work appears in journals such as Biomedical Reports, Oncotarget, PeerJ, PLoS ONE and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.